Beta Wealth Group Inc. Takes Position in Agilent Technologies, Inc. (NYSE:A)

Beta Wealth Group Inc. purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:AFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,814 shares of the medical research company’s stock, valued at approximately $252,000.

Several other institutional investors and hedge funds have also modified their holdings of A. MV Capital Management Inc. grew its holdings in shares of Agilent Technologies by 120.7% during the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after acquiring an additional 105 shares in the last quarter. VisionPoint Advisory Group LLC bought a new stake in Agilent Technologies in the fourth quarter worth $29,000. Baystate Wealth Management LLC boosted its holdings in Agilent Technologies by 107.3% in the fourth quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after purchasing an additional 133 shares in the last quarter. Rosenberg Matthew Hamilton boosted its holdings in Agilent Technologies by 51.1% in the fourth quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after purchasing an additional 96 shares in the last quarter. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in Agilent Technologies in the fourth quarter worth $39,000.

Insider Buying and Selling

In related news, SVP Philip Binns sold 2,827 shares of the stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the completion of the transaction, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Heidi Fields sold 1,658 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total transaction of $239,315.72. Following the completion of the sale, the director now owns 54,976 shares of the company’s stock, valued at $7,935,235.84. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Philip Binns sold 2,827 shares of the firm’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the sale, the senior vice president now directly owns 9,997 shares of the company’s stock, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Insiders sold 61,610 shares of company stock valued at $9,220,333 over the last quarter.

Agilent Technologies Stock Performance

Shares of A traded up $0.11 during trading hours on Friday, reaching $150.66. 784,333 shares of the company traded hands, compared to its average volume of 1,280,669. The stock’s fifty day moving average is $144.06 and its 200 day moving average is $136.38. The stock has a market cap of $44.15 billion, a P/E ratio of 35.87, a price-to-earnings-growth ratio of 4.04 and a beta of 1.13. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.07. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The firm had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the business posted $1.37 earnings per share. The company’s quarterly revenue was down 5.5% compared to the same quarter last year. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.5 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.63%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.38%.

Analysts Set New Price Targets

A has been the subject of a number of recent research reports. UBS Group upped their price objective on shares of Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Evercore ISI upped their price objective on shares of Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. Barclays upped their price objective on shares of Agilent Technologies from $125.00 to $135.00 and gave the stock an “underweight” rating in a report on Wednesday, April 10th. Stifel Nicolaus upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $145.00 to $163.00 in a report on Friday, April 5th. Finally, Oppenheimer upped their price target on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $141.06.

Get Our Latest Analysis on A

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Read More

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.